Differential brain opioid receptor availability in central and peripheral neuropathic pain

Pain

Volumn 127, Issue 1-2, 2007, Pages 183-194

  Maarrawi, Joseph ^a,b   Peyron, Roland ^a,c   Mertens, Patrick ^a,b,e   Costes, Nicolas ^d   Magnin, Michel ^a   Sindou, Marc ^b   Laurent, Bernard ^a,c   Garcia Larrea, Luis ^a  

^a INSERM   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c SERVICE DE NEUROLOGIE   (France)

^d CERMEP IMAGERIE DU VIVANT   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

Central post stroke pain; Neuropathic pain; Opioid receptors; Positron emission tomography; 11C Diprenorphine

Indexed keywords

BRAIN RECEPTOR; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; DEXTROPROPOXYPHENE; GABAPENTIN; MORPHINE; OPIATE; OPIATE RECEPTOR; OXCARBAZEPINE; PARACETAMOL; TRAMADOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMISPHERE; HUMAN; IN VIVO STUDY; INSULA; MALE; MESENCEPHALON; METABOLIC INHIBITION; NEUROANATOMY; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR DENSITY; STROKE; TEMPORAL CORTEX; THALAMUS;

EID: 33845803075     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.10.013     Document Type: Article

References (34)

1. Albe-Fessard D., Berkley K.J., Kruger L., Ralston III H.J., and Willis Jr. W.D. Diencephalic mechanisms of pain sensation. Brain Res 356 (1985) 217-296
2. Baron J.C., Levasseur M., Mazoyer B., Legault-Demare F., Mauguiere F., Pappata S., Jedynak P., Derome P., Cambier J., Tran-Dinh S., et al. Thalamocortical diaschisis: positron emission tomography in humans. J Neurol Neurosurg Psychiatry 55 (1992) 935-942
3. 11C]-carfentanil and positron emission tomography (PET). Pain 99 (2002) 589-598
4. Benedetti F., Vighetti S., Amanzio M., Casadio C., Oliaro A., Bergamasco B., et al. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain 74 (1998) 205-211
5. Brix G., Zaers J., Adam L.E., Bellemann M.E., Ostertag H., Trojan H., et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38 (1997) 1614-1623
6. Chen F., and Lawrence A.J. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats. J Pharmacol Exp Ther 310 (2004) 1020-1026
7. Chung S.K., Cohen R.S., and Pfaff D.W. Transneuronal degeneration in the midbrain central gray following chemical lesions in the ventromedial nucleus: a qualitative and quantitative analysis. Neuroscience 38 (1990) 409-426
8. Dellemijn P.L.I., and Vanneste J.A.L. Randomised double blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 340 (1997) 753-758
9. Dellemijn P.L.I., VanDuijn H., and Vanneste J.A.L. Pro1onged treatment with transderma1 fentanyl in neuropathic pain. J Pain Symptom Manage 16 (1998) 220-229
10. Feeney D.M., and Baron J.C. Diaschisis. Stroke 17 (1986) 817-830
11. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 5 (2004) 565-575
12. 11C]carfentanil binding to opiate receptors in humans measured by positron emission tomography. J Cereb Blood Flow Metab 9 (1989) 398-409
13. Iadarola M.J., Brady L.S., Draisci G., and Naranjo J.R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 35 (1988) 313-326
14. Jones A.K.P., Cunningham V.J., Ha-Kawa S., Fujiwara T., Luthra S.K., Silva S., et al. Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumathoid arthritis. Br J Rheumatol 33 (1994) 909-916
15. 11C]diprenorphine binding and PET. Eur J Pain 8 (2004) 479-485
16. Luthra S.K., Brady F., Turton D.R., Brown D.J., Dowsett K., Waters S.L., et al. Automated radiosyntheses of [6-0-methyl-11C] diprenorphine and [6-0-methyl-11C] buprenorphine from 3-06trityl protected precursors. Appl Radiat Isot 45 (1994) 857-873
17. Marchand F., Ardid D., Chapuy E., Alloui A., Jourdan D., and Eschalier A. Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther 307 (2003) 268-274
18. Millan M.J., Millan M.H., Czlonkowski A., Hollt V., Pilcher C.W., Herz A., et al. A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis. J Neurosci 6 (1986) 899-906
19. Peyron R., Garcia-Larrea L., Gregoire M.C., Convers P., Lavenne F., Veyre L., et al. Allodynia after lateral-medullary (Wallenberg) infarct. A PET study. Brain 121 (1998) 345-356
20. Rickham P.P. Human experimentation. Code of ethics of the World medical association. Delaration of Helsinki. Br Med J 5402 (1964) 177
21. Rowbotham M.C., Reisner-Keller L.A., and Fields H.L. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41 (1991) 1024-1028
22. Rowbotham M.C., Twilling L., Davies P.S., Reisner L., Taylor K., and Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 348 (2003) 1223-1232
23. Sadzot B., Mayberg H.S., and Frost J.J. Detection and quantification of opiate receptors in man by positron emission tomography. Potential applications to the study of pain. Neurophysiol Clin 20 (1990) 323-334
24. Sprenger T., Berthele A., Platzer S., Boecker H., and Tolle T.R. What to learn from in vivo opioidergic brain imaging?. Eur J Pain 9 (2005) 117-121
25. Vaccarino A.L., Olson G.A., Olson R.D., and Kastin A.J. Endogenous opiates: 1998. Peptides 20 (1999) 1527-1574
26. Varona A., Gil J., Saracibar G., Maza J.L., Echevarria E., and Irazusta J. Effects of imipramine treatment on delta-opioid receptors of the rat brain cortex and striatum. Arzneimittelforschung 53 (2003) 21-25
27. Watson C.P., and Babul N. Efficacy of oxycodone in neuropathic pain: a randomised trial in postherpetic neuralgia. Neurology 50 (1998) 1837-1841
28. 11C]diprenorphine PET study. Pain 108 (2004) 213-220
29. Woods R.P., Grafton S.T., Holmes C.J., Cherry S.R., and Mazziotta J.C. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22 (1998) 139-152
30. Yonehara N., Kudo T., Iwatsubo K., Maeda S., Saito K., and Inoki R. A possible involvement of the central endorphin system in the autoanalgesia induced by chronic administration of Freund's adjuvant solution in rats. Pain 17 (1983) 91-98
31. Zangen A., Herzberg U., Vogel Z., and Yadid G. Nociceptive stimulus induces release of endogenous beta-endorphin in the rat brain. Neuroscience 85 (1998) 659-662
32. Zubieta J.K., Dannals R.F., and Frost J.J. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry 156 (1999) 842-848
33. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293 (2001) 311-315
34. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., et al. Mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci 22 (2002) 5100-5107